Trafa Pharmaceutical Inc. — Class I: Trafa Pharmaceuticals Inc. brand ORGANIC MORINGA LEAF POWDER; NET WEIGHT: 15 KGS; packaged
Trafa Pharmaceutical Inc. has initiated a Class I recall for its Organic Moringa Leaf Powder due to potential Salmonella contamination. The affected product is distributed in 15 KG brown paper bags with white labels.
This recall affects Trafa Pharmaceutical Inc., its downstream distributors, and manufacturing or packaging facilities utilizing bulk organic moringa leaf powder.
A Class I designation signifies the highest level of regulatory concern, indicating that the FDA believes exposure to the product could cause serious health consequences. This suggests a significant failure in pathogen controls or environmental monitoring at the production or handling level, which likely necessitates a thorough root cause analysis and a review of the firm's Food Safety Plan.
Quality teams should verify if any 15 KG units of organic moringa leaf powder are in inventory and immediately secure them. Supply chain leads should evaluate the supplier's sanitation controls and review certificates of analysis for recent shipments of botanical powders.
Class I. Reason: Potential contamination with Salmonella. Product: Trafa Pharmaceuticals Inc. brand ORGANIC MORINGA LEAF POWDER; NET WEIGHT: 15 KGS; packaged in brown paper bags with a white label. Firm: Trafa Pharmaceutical Inc. (Chicopee MA United States). Status: Ongoing.
Open in openFDA / FDA.gov